Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Dementia, Multi-Infarct D015161 2 associated lipids
Capillary Leak Syndrome D019559 2 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Ileal Diseases D007077 3 associated lipids
Platelet Storage Pool Deficiency D010981 3 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Extravasation of Diagnostic and Therapeutic Materials D005119 3 associated lipids
Enterocolitis, Necrotizing D020345 3 associated lipids
Dyslexia D004410 3 associated lipids
Leukemia, Eosinophilic, Acute D015472 3 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Davoine F et al. Interleukin-12 inhibits eosinophil degranulation and migration but does not promote eosinophil apoptosis. 2006 Int. Arch. Allergy Immunol. pmid:16735797
Lima RG et al. Interaction of macrophages with apoptotic cells enhances HIV Type 1 replication through PGE2, PAF, and vitronectin receptor. 2006 AIDS Res. Hum. Retroviruses pmid:16910832
Gora S et al. The proinflammatory mediator Platelet Activating Factor is an effective substrate for human group X secreted phospholipase A2. 2006 Biochim. Biophys. Acta pmid:16962371
Kassuya CA et al. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor. 2006 Eur. J. Pharmacol. pmid:16925995
Cauwels A et al. Anaphylactic shock depends on PI3K and eNOS-derived NO. 2006 J. Clin. Invest. pmid:16886062
Wolf P et al. Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis. 2006 Am. J. Pathol. pmid:16936256
Pirbhai M et al. The secreted protease factor CPAF is responsible for degrading pro-apoptotic BH3-only proteins in Chlamydia trachomatis-infected cells. 2006 J. Biol. Chem. pmid:16940052
Harputluoglu MM et al. The effects of Gingko biloba extract on acetic acid-induced colitis in rats. 2006 Turk J Gastroenterol pmid:16941250
Han JI et al. RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization. 2006 J. Leukoc. Biol. pmid:16565322
Servillo L et al. Lysophospholipid transacetylase in the regulation of PAF levels in human monocytes and macrophages. 2006 FASEB J. pmid:16571775
Flamand N et al. Inhibition of platelet-activating factor biosynthesis by adenosine and histamine in human neutrophils: involvement of cPLA2alpha and reversal by lyso-PAF. 2006 J. Leukoc. Biol. pmid:16501051
He J and Bazan HE Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis. 2006 Invest. Ophthalmol. Vis. Sci. pmid:16505020
Barthomeuf C et al. Inhibition of sphingosine-1-phosphate- and vascular endothelial growth factor-induced endothelial cell chemotaxis by red grape skin polyphenols correlates with a decrease in early platelet-activating factor synthesis. 2006 Free Radic. Biol. Med. pmid:16458188
Denizot Y et al. Platelet-activating factor and human meningiomas. 2006 Neuropathol. Appl. Neurobiol. pmid:17083481
Wang GD et al. Platelet-activating factor in the enteric nervous system of the guinea pig small intestine. 2006 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:17030900
Herman AG and Stockwell BR Enzyme annotation with chemical tools. 2006 Chem. Biol. pmid:17052604
Chiang KP et al. An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling. 2006 Chem. Biol. pmid:17052608
Brown SL et al. Activation and regulation of platelet-activating factor receptor: role of G(i) and G(q) in receptor-mediated chemotactic, cytotoxic, and cross-regulatory signals. 2006 J. Immunol. pmid:16920964
Baker KE et al. Nupafant, a PAF-antagonist prototype for suppression of ventricular fibrillation without liability for QT prolongation? 2006 Br. J. Pharmacol. pmid:16921398
Kim DH et al. Effects of tumor necrosis factor alpha antagonist, platelet activating factor antagonist, and nitric oxide synthase inhibitor on experimental otitis media with effusion. 2006 Ann. Otol. Rhinol. Laryngol. pmid:16944661
Vahidy WH et al. Effects of intracerebroventricular injections of free fatty acids, lysophospholipids, or platelet activating factor in a mouse model of orofacial pain. 2006 Exp Brain Res pmid:16947060
Matsumura Y et al. A role for inflammatory mediators in the induction of immunoregulatory B cells. 2006 J. Immunol. pmid:16982922
Slomiany BL and Slomiany A Porphyromonas gingivalis lipopolysaccharide-induced cytosolic phospholipase A2 activation interferes with salivary mucin synthesis via platelet activating factor generation. 2006 Inflammopharmacology pmid:16983494
Zhang Q et al. Activation of platelet-activating factor receptor in SZ95 sebocytes results in inflammatory cytokine and prostaglandin E2 production. 2006 Exp. Dermatol. pmid:16984258
Hartvigsen K et al. 1 -O-alkyl-2-(omega-oxo)acyl-sn-glycerols from shark oil and human milk fat are potential precursors of PAF mimics and GHB. 2006 Lipids pmid:17069352
Tabarés-Seisdedos R et al. Variations in genes regulating neuronal migration predict reduced prefrontal cognition in schizophrenia and bipolar subjects from mediterranean Spain: a preliminary study. 2006 Neuroscience pmid:16549273
Heon Seo K et al. Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation. 2006 Cancer Res. pmid:16651419
Doi K et al. Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. 2006 Am. J. Pathol. pmid:16651609
Coleus forskohlii. Monograph. 2006 Altern Med Rev pmid:16597194
Fernandes CJ and O'Donovan DJ Platelet transfusions in infants with necrotizing enterocolitis. 2006 Curr. Hematol. Rep. pmid:16537050
Maliba R et al. Angiopoietins-1 and -2 are both capable of mediating endothelial PAF synthesis: intracellular signalling pathways. 2006 Cell. Signal. pmid:16617006
Jauchem JR The role of autacoids and the autonomic nervous system in cardiovascular responses to radio-frequency energy heating. 2006 Auton Autacoid Pharmacol pmid:16553641
Bi W et al. Dual-acting agents that possess free radical scavenging and antithrombotic activities: design, synthesis, and evaluation of phenolic tetrahydro-beta-carboline RGD peptide conjugates. 2006 Bioorg. Med. Chem. Lett. pmid:16797986
Purnell ET et al. Influence of the preimplantation embryo development (Ped) gene on embryonic platelet-activating factor (PAF) levels. 2006 J. Assist. Reprod. Genet. pmid:16799834
Slomiany BL and Slomiany A Cytosolic phospholipase A2 activation in Helicobacter pylori lipopolysaccharide-induced interference with gastric mucin synthesis. 2006 IUBMB Life pmid:16754300
Moreno SE et al. Signaling via platelet-activating factor receptors accounts for the impairment of neutrophil migration in polymicrobial sepsis. 2006 J. Immunol. pmid:16818786
Machado EM et al. WEB 2086, a platelet-activating factor antagonist, inhibits prophenoloxidase-activating system and hemocyte microaggregation reactions induced by Trypanosoma rangeli infection in Rhodnius prolixus hemolymph. 2006 J. Insect Physiol. pmid:16777137
Blanchet MR et al. Dimethyphenylpiperazinium, a nicotinic receptor agonist, downregulates inflammation in monocytes/macrophages through PI3K and PLC chronic activation. 2006 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:16782754
Mao YJ et al. [Effect of ginkgolide B on the function of rat aorta smooth cells and U937 cells stimulated by oxLDL]. 2006 Yao Xue Xue Bao pmid:16683525
Ko HM et al. Platelet-activating factor-induced NF-kappaB activation enhances VEGF expression through a decrease in p53 activity. 2006 FEBS Lett. pmid:16684540
Hermle T et al. Decreased cation channel activity and blunted channel-dependent eryptosis in neonatal erythrocytes. 2006 Am. J. Physiol., Cell Physiol. pmid:16723509
Fonseca FV et al. Characterization of a new platelet aggregating factor from crotoxin Crotalus durissus cascavella venom. 2006 Protein J. pmid:16729248
Wang C et al. Total synthesis of (+/-)-paeonilide. 2006 Org. Lett. pmid:16737293
Kaul DK et al. Peptides based on alphaV-binding domains of erythrocyte ICAM-4 inhibit sickle red cell-endothelial interactions and vaso-occlusion in the microcirculation. 2006 Am. J. Physiol., Cell Physiol. pmid:16738001
Thaete LG and Neerhof MG Endothelin and platelet-activating factor: significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the rat. 2006 Am. J. Obstet. Gynecol. pmid:16579936
Karantonis HC et al. In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits. 2006 Nutr Metab Cardiovasc Dis pmid:16580585
Balestrieri C et al. Relative effects of phenolic constituents from Yucca schidigera Roezl. bark on Kaposi's sarcoma cell proliferation, migration, and PAF synthesis. 2006 Biochem. Pharmacol. pmid:16580641
Kikuchi I et al. Eosinophil trans-basement membrane migration induced by interleukin-8 and neutrophils. 2006 Am. J. Respir. Cell Mol. Biol. pmid:16456187
Mauri P et al. LC-MS characterization of terpene lactones in plasma of experimental animals treated with Ginkgo biloba extracts Correlation with pharmacological activity. 2006 J Pharm Biomed Anal pmid:16343838
Eckford PD and Sharom FJ P-glycoprotein (ABCB1) interacts directly with lipid-based anti-cancer drugs and platelet-activating factors. 2006 Biochem. Cell Biol. pmid:17215888
Subbanna PK and Tyagi MG PAF antagonism modifies neuroprotective action of histone deacetylase and calcineurin phosphatase inhibitors in mice. 2006 Indian J. Exp. Biol. pmid:17205708
Fang H et al. Anaphylactic reaction induced by Toxoplasma gondii-derived heat shock protein 70. 2006 Int. Immunol. pmid:16943259
Antonopoulou S et al. Effect of traditional Greek Mediterranean meals on platelet aggregation in normal subjects and in patients with type 2 diabetes mellitus. 2006 J Med Food pmid:17004898
Gomes MT et al. Platelet-activating factor-like activity isolated from Trypanosoma cruzi. 2006 Int. J. Parasitol. pmid:16337632
Desaulniers P et al. Characterization of an activation factor released from human neutrophils after stimulation by triclinic monosodium urate crystals. 2006 J. Rheumatol. pmid:16652423
Louis NA et al. Lipid mediator networks and leukocyte transmigration. 2005 Sep-Oct Prostaglandins Leukot. Essent. Fatty Acids pmid:15979294
Spitzer AL et al. Early nonenhanced abdominal computed tomography can predict mortality in severe acute pancreatitis. 2005 Sep-Oct J. Gastrointest. Surg. pmid:16137586
Akyürek N et al. The effect of platelet activating factor antagonist BN 52021 on bacterial translocation and ICAM-I expression in experimental obstructive jaundice. 2005 Sep-Oct J Invest Surg pmid:16249168
O'Neill C The role of paf in embryo physiology. 2005 May-Jun Hum. Reprod. Update pmid:15790601
Krasheninnikov ME and Pliashkevich IuG [Effects of the platelet activating factor on the proliferation and IgE secretion by U-266BL human myeloma cells]. 2005 Jul-Aug Eksp Klin Farmakol pmid:16193656
Marrache AM et al. Intracellular signaling of lipid mediators via cognate nuclear G protein-coupled receptors. 2005 Jan-Apr Endothelium pmid:16036317
Lemieux C et al. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. 2005 Blood pmid:15498854
Mishra RK et al. Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K). 2005 Allergy pmid:16076309
Jin Y et al. Human resting CD16-, CD16+ and IL-2-, IL-12-, IL-15- or IFN-alpha-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor. 2005 Eur. J. Immunol. pmid:16078278
Meyer MC et al. Potential role for mast cell tryptase in recruitment of inflammatory cells to endothelium. 2005 Am. J. Physiol., Cell Physiol. pmid:16079184
Fell JM Neonatal inflammatory intestinal diseases: necrotising enterocolitis and allergic colitis. 2005 Early Hum. Dev. pmid:15707723
Schaloske RH et al. Molecular characterization of the lipopolysaccharide/platelet activating factor- and zymosan-induced pathways leading to prostaglandin production in P388D1 macrophages. 2005 Biochim. Biophys. Acta pmid:15708354
Mann NS and Leung JW Pathogenesis of esophageal rings in eosinophilic esophagitis. 2005 Med. Hypotheses pmid:15617859
Cheng L et al. Platelet-activating factor and prostaglandin E2 impair esophageal ACh release in experimental esophagitis. 2005 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:15890711
Qu XW et al. Tetrahydrobiopterin prevents platelet-activating factor-induced intestinal hypoperfusion and necrosis: Role of neuronal nitric oxide synthase. 2005 Crit. Care Med. pmid:15891335
Gilli UO et al. Human polymorphonuclear neutrophils are recruited by porcine chemokines acting on CXC chemokine receptor 2, and platelet-activating factor. 2005 Transplantation pmid:15912099
Park EJ et al. Dietary ganglioside decreases cholesterol content, caveolin expression and inflammatory mediators in rat intestinal microdomains. 2005 Glycobiology pmid:15917432
Owen JS et al. Stress-induced platelet-activating factor synthesis in human neutrophils. 2005 Biochim. Biophys. Acta pmid:15863359
Kita Y et al. A multiplex quantitation method for eicosanoids and platelet-activating factor using column-switching reversed-phase liquid chromatography-tandem mass spectrometry. 2005 Anal. Biochem. pmid:15958190
Fang YH et al. [Relationship between serum vWF and PAF in type 2 diabetic patients and diabetic nephropathy]. 2005 Di Yi Jun Yi Da Xue Xue Bao pmid:15958323
Vinson SM et al. Neutrophil adherence to bladder microvascular endothelial cells following platelet-activating factor acetylhydrolase inhibition. 2005 J. Pharmacol. Exp. Ther. pmid:15937147
Sumita C et al. Platelet activating factor induces cytoskeletal reorganization through Rho family pathway in THP-1 macrophages. 2005 FEBS Lett. pmid:16004986
Ou-Yang XY et al. [Inhibitory effect of ginkgolide B on angiogenesis in chronic inflammation]. 2005 Yao Xue Xue Bao pmid:16011257
Estellés R et al. Effect of boldine, secoboldine, and boldine methine on angiotensin II-induced neutrophil recruitment in vivo. 2005 J. Leukoc. Biol. pmid:15944212
Zhao T and Bokoch GM Critical role of proline-rich tyrosine kinase 2 in reversion of the adhesion-mediated suppression of reactive oxygen species generation by human neutrophils. 2005 J. Immunol. pmid:15944312
McLarnon JG et al. Perturbations in calcium-mediated signal transduction in microglia from Alzheimer's disease patients. 2005 J. Neurosci. Res. pmid:15948178
Cao HC et al. Determination of platelet-activating factor by reverse phase high-performance liquid chromatography and its application in viral hepatitis. 2005 World J. Gastroenterol. pmid:16437644
Asada Y [Inflammatory and immune responses in arterial thrombus formation]. 2005 Rinsho Ketsueki pmid:16447700
Rubin BB et al. Cytosolic phospholipase A2-alpha is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cPLA2-alpha does not regulate neutrophil NADPH oxidase activity. 2005 J. Biol. Chem. pmid:15475363
Zinchuk O et al. Direct action of platelet activating factor (PAF) induces eosinophil accumulation and enhances expression of PAF receptors in conjunctivitis. 2005 Mol. Vis. pmid:15735601
Lang PA et al. Stimulation of erythrocyte ceramide formation by platelet-activating factor. 2005 J. Cell. Sci. pmid:15741229
Connelly PW et al. Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite. 2005 Free Radic. Biol. Med. pmid:15607900
Ivanov AI et al. Albumin is not an irreplaceable carrier for amphipathic mediators of thermoregulatory responses to LPS: compensatory role of alpha1-acid glycoprotein. 2005 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:15576666
Denizot Y et al. Platelet-activating factor does not stimulate cAMP formation from immature forms of freshly isolated leukaemic blasts. 2005 Leuk. Lymphoma pmid:15621790
Meyer MC et al. Calcium-independent phospholipase A2 is regulated by a novel protein kinase C in human coronary artery endothelial cells. 2005 Am. J. Physiol., Cell Physiol. pmid:15643055
Granger J and Remick D Acute pancreatitis: models, markers, and mediators. 2005 Shock pmid:16374372
Tian X and Bazan NG Neuroprotection by platelet-activating factor antagonism. 2005 Ann. N. Y. Acad. Sci. pmid:16179552
Zhang Q et al. Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor. 2005 J. Clin. Invest. pmid:16184199
Pexa A and Deussen A Modulation of ecto-5'-nucleotidase by phospholipids in human umbilical vein endothelial cells (HUVEC). 2005 Naunyn Schmiedebergs Arch. Pharmacol. pmid:16200394
Karantonis HC et al. Synthesis and biological evaluation of novel steroid-modified ether phospholipids. 2005 Chem. Phys. Lipids pmid:16202400
Antonopoulou S et al. Bioactive polar lipids from Chroococcidiopsis sp. (Cyanobacteria). 2005 Comp. Biochem. Physiol. B, Biochem. Mol. Biol. pmid:16198133
Hu G et al. Isoflurane prevents platelets from enhancing neutrophil-induced coronary endothelial dysfunction. 2005 Anesth. Analg. pmid:16243978
Okumura N et al. Platelet-activating factor in human normal tears. 2005 Curr. Eye Res. pmid:16251126
Ko HM et al. Platelet-activating factor induces matrix metalloproteinase-9 expression through Ca(2+)- or PI3K-dependent signaling pathway in a human vascular endothelial cell line. 2005 FEBS Lett. pmid:16288746
Ward JR et al. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. 2005 Thromb. Haemost. pmid:16270639